• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: Tecovirimat     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:WikicatPoxviruses, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)

Type: Thingdul:ChemicalObjectchemical substanceDrugyago:WikicatAntiviralsyago:WikicatMolecularFormulasyago:Abstraction100002137yago:Agent109190918yago:Agent114778436yago:AnimalVirus101335659yago:Antiviral102725367yago:CausalAgent100007347yago:Communication100033020yago:Drug103247620yago:Formula106816935yago:InfectiousAgent109312843yago:LivingThing100004258yago:Matter100020827yago:Medicine103740161yago:Message106598915yago:Microorganism101326291yago:MolecularFormula106817173yago:Object100002684yago:Organism100004475yago:PhysicalEntity100001930yago:Poxvirus101333731drugyago:Statement106722453yago:Substance100020090yago:Virus101328702yago:Whole100003553yago:WikicatPoxviruses New Facet based on Instances of this Class

Tecovirimat, sold under the brand name Tpoxx among others, is an antiviral medication with activity against orthopoxviruses such as smallpox and monkeypox. It is the first antipoxviral drug approved in the United States. It is an inhibitor of the orthopoxvirus VP37 envelope wrapping protein. Two million doses of tecovirimat are stockpiled in the US Strategic National Stockpile should an orthopoxvirus-based bioterror attack occur. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.